Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older

Conditions

• Herpes Zoster
• Shingles

Interventions

• BIOLOGICAL: Amezosvatein Antigen High Dose Arm A
• BIOLOGICAL: Amezosvatein Antigen Low Dose Arm B
• BIOLOGICAL: Shingrix
• BIOLOGICAL: Amezosvatein Adjuvant Dose Arm D
• BIOLOGICAL: Amezosvatein Adjuvant Dose Arm F
• BIOLOGICAL: Amezosvatein Adjuvant Dose Arm H
• BIOLOGICAL: Amezosvatein Adjuvant Dose Arm J
• BIOLOGICAL: Amezosvatein Adjuvant Dose Arm L

Sponsor

Curevo Inc